The Vitamin D Receptor Gene Bat (Cca) Haplotype Impairs the Response to Pegylated-Interferon/ Ribavirin-Based Therapy in Chronic Hepatitis C Patients
Katharina Baur(University Hospital Zurich), Pascal Frei(University Hospital Zurich), Heike A. Bischoff‐Ferrari(Felix Platter-Hospital), Arnold von Eckardstein(University Hospital of Zurich), Beat Müllhaupt(University Hospital of Zurich), Bruno Stieger(University Hospital of Zurich), Andreas Geier(Swiss Integrative Center for Human Health), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Rika Iwata(University Hospital Zurich), Burkhardt Seifert(Omega Consult (Slovenia)), Johannes Schmitt(University Hospital Zurich)
Cited by 36
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
|American Journal of Clinical Nutrition|2006|2.4k
Fracture Prevention With Vitamin D Supplementation
|JAMA|2005|1.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
Effect of Vitamin D on Falls
|JAMA|2004|1.3k